FT Health: Vaccines

Vaccine research grows vigorously, propelled by rising world demand to fight existing diseases and to guard against new threats. Ebola and Zika have recently caused huge international alarm. Yet the Trump era may give voice to increased vaccine scepticism

Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists

Chinese black market case shines light on poor regulation

Plans include using one virus to attack another

Moves to widen vaccination coverage meet strong political opposition

Proponents say vaccines made of RNA and DNA will prove safer and cheaper

Medical community worries as a powerful new voice amplifies support for the ‘vaccine hesitant’

International team of specialists takes fight to emerging lethal infections that as yet have no name

Successful trials and wide-ranging approaches continue to stir hopes of new means of tackling the disease